Table 1.
Correlation between RASEF expression and clinical indicators of colorectal cancer patients: Spearman’s correlation analysis
| Gender | Age | Tumor size | Pathological grading | T | N | M | Clinical grading | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Spearman’s rho | Cytoplasm RE expression | Tumor | Correlation Coefficient | -.035 | -.017 | .064 | .010 | -.081 | .005 | .125 | .054 |
| Sig. (2-tailed) | .752 | .878 | .562 | .927 | .480 | .960 | .251 | .628 | |||
| N | 85 | 81 | 85 | 86 | 79 | 86 | 86 | 84 | |||
| Adjacent | Correlation Coefficient | -.032 | -.017 | -.103 | -.107 | -.142 | .066 | -.156 | -.010 | ||
| Sig. (2-tailed) | .779 | .885 | .356 | .336 | .220 | .552 | .160 | .930 | |||
| N | 82 | 78 | 82 | 83 | 76 | 83 | 83 | 81 | |||
| Nucleus RE expression | Tumor | Correlation Coefficient | .024 | .088 | .154 | .162 | .156 | .007 | .010 | .055 | |
| Sig. (2-tailed) | .824 | .433 | .156 | .133 | .167 | .950 | .927 | .616 | |||
| N | 86 | 82 | 86 | 87 | 80 | 87 | 87 | 85 | |||
| Adjacent | Correlation Coefficient | -.067 | -.101 | -.001 | .242* | .100 | .027 | .146 | .068 | ||
| Sig. 2-tailed) | .549 | .378 | .992 | .027 | .389 | .808 | .188 | .547 | |||
| N | 82 | 78 | 82 | 83 | 76 | 83 | 83 | 81 | |||
**Correlation is significant at the 0.01 level (2-tailed).
*
Correlation is significant at the 0.05 level (2-tailed).